When a diagnostics company gains in-network status with a major U.S. payer (covering 10%+ of commercial lives) after guidance has been issued — or management explicitly excludes it from guidance — a near-term beat is structurally set up. The mechanism: (1) in-network status reduces ordering friction and improves reimbursement certainty, but (2) provider ordering patterns change slowly — EHR order sets must be updated, insurance verification workflows retrained, and new provider relationships built. Management has no track record of this payer's utilization ramp pace and conservatively excludes it entirely, rather than risk a forward guidance miss. The result: 2–4 quarters of upside surprises as ordering friction unwinds and reimbursement collection improves.
When screening diagnostics companies for near-term beat probability, flag explicitly-excluded payer in-network events. The larger the payer (UHC > Aetna > BCBS regional), the larger the unmodeled impact. The utilization ramp typically takes 2–4 quarters to show in volume data, then persists. Model the contribution as a back-half-weighted revenue upside scenario. Do not assume the market has priced this in — sell-side models often share the same guidance anchor.